New to the thread...so they have TGA and CE approval and the Android is in Beta phase and IOs up and running.
Talk of FDA is circa end of '18/'19.
Can someone outline what $$ contracts are in place currently and in the event FDA is not approved (as we saw with RAP based on clinical trials) what impact that would have on revenue and their target market. Seems they are lining up their ducks perfectly in the Oz market.
Class of device for FDA obviously not known yet - would want non-medial grade to expedite FDA surely?
Just trying to catch up to you folk!
PCK Price at posting:
5.7¢ Sentiment: Buy Disclosure: Not Held
